In 2008, I qualified for a clinical trial testing a new type of valve for aortic valve replacement. After meeting with Dr. Pettersson1 , I was convinced that the trial was something I needed to do. I was already in heart failure, so I was fortunate that the surgery could be performed within a month. 

My operation went well, and the trial also was extremely successful. In 2011, the FDA approved the new valve. It was designed to last 15 to 20 years, versus the previous 10-year lifespan. When you compare 10 years to 20 years, how could I say no? I did happen to be one of the very few who needed to have another surgery, which I had in 2016, also with Dr. Pettersson. The valve wasn’t defective; it just didn’t work for me as hoped. Everybody has a different body chemistry. 

The trial was a very positive experience. Some of my friends asked, “Why are you doing this?” I told them it was a great opportunity to participate in something bigger than myself. Everyone was just absolutely wonderful.

 

Shortly after her second surgery, Carol Olson took a two-week cruise. Since then, she has been enjoying gardening, cross-country skiing, walking and volunteering.

Photo of Carol Olson

Photo: Courtesy of Carol Olson

Note

  1. Gosta Pettersson, MD, PhD, was Vice Chair of Thoracic & Cardiovascular Surgery